Avicenna Military Hospital of Marrakech
Marrakesh, Marrakesh-Safi, 40160, Morocco
NCT Number: NCT07404280
The goal of this study is to learn if a nutritional intervention adapted to Moroccan dietary habits can improve blood sugar control in adults with Type 2 Diabetes. The main questions it aims to answer are:
* Does a personalized diet based on Moroccan culinary traditions improve long-term blood sugar levels (HbA1c)? * How does this intervention affect daily blood sugar fluctuations measured as interstitial glucose? * Does the intervention lead to changes in body measurements, such as weight and Body Mass Index (BMI)?
Participants will:
* Wear a Continuous Glucose Monitor (CGM) to track sugar levels in real-time. * Keep a detailed food diary of all foods and drinks consumed. * Follow their usual diet for the first 7 days to establish a baseline. * Receive personalized dietary advice specifically tailored to Moroccan food habits. * Return for clinical check-ups at 14, 90, and 180 days for blood tests and body measurements.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Marrakesh, Marrakesh-Safi, 40160, Morocco
This study follows a quasi-experimental, before-after design conducted in a clinical setting. The research is structured to evaluate the metabolic and anthropometric response of Type 2 Diabetic (T2D) patients to a culturally tailored nutritional intervention. The trial is longitudinal, spanning a total duration of 180 days per participant.
Intervention Phases:
The protocol is divided into distinct chronological stages to capture both baseline data and intervention outcomes:
Data collection and Scientific tools:
The study utilizes high-precision monitoring tools to ensure data reliability:
Statistical Analysis Plan Data will be analyzed using a within-subject comparison. Descriptive statistics will summarize baseline characteristics. Paired t-tests and ANOVA will be employed to compare glycemic and anthropometric variables across the four time points (T0, T7, T90, T180), with a significance level set to p<0.05. Additionally, Pearson or Spearman correlation tests and Artificial Intelligence techniques will examine the association between specific Moroccan dietary patterns and glycemic fluctuations.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention consists of a structured diet plan that integrates traditional Moroccan ingredients and cooking methods while optimizing for glycemic control. It involves:
Time frame: Baseline (Day 0 to Day 7) compared to the final follow-up at Day 180.
Evaluation of the impact of the Moroccan-adapted nutritional intervention on daily glucose fluctuations. This is measured using a Continuous Glucose Monitoring (CGM) system to record real-time glucose data.
Time frame: Baseline (Day 0) and Day 180.
Measurement of glycated hemoglobin to assess long-term glycemic control through laboratory samples.
Time frame: Baseline (Day 0) and Day 180.
Calculation of BMI based on weight and height measurements.
Time frame: Baseline (Day 0) and Day 180.
Anthropometric measurement of the waist to evaluate changes in abdominal adiposity.
Time frame: Baseline (Day 0) and Day 180.
Assessment of body fat and lean mass using bioelectrical impedance.
Time frame: Baseline (Day 7) compared to Day 180.
Evaluation of changes in dietary habits and adherence to the personalized Moroccan-adapted recommendations using food diaries.
Avicenna Military Hospital
Other
Intervention of Artificial Intelligence in the Management of Nutritional Therapy Applied to Moroccan Type 2 Diabetics - Al-Khawarizmi Project
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07325435
Diabetes Mellitus, Diabetes Mellitus, Type 2
Brooklyn, New York, United States
View Trial DetailsNCT07144670
Adipose Tissue, Adipose Tissue Inflammation
Svendborg, Denmark
View Trial DetailsNCT07156370
Adrenal Gland Diseases, Adrenocortical Hyperfunction
Shanghai, China
View Trial DetailsNCT07097415
Diabetes Mellitus, Diabetes Mellitus, Type 2
Ningbo, Zhejiang, China
View Trial Details